JS Link Inc, formerly DNA Link Inc, is a Korea-based company mainly engaged in the genome analysis business. The Company mainly engages in the research and development of genome analysis services and personal genome analysis service products used for disease prevention, diagnosis, and treatment. The Company also mainly engages in the manufacture and sale of coronavirus disease 2019 (COVID-19) diagnostic kits. In addition, the Company engages in the research and development of â€˜Avatar Mouse,â€™ an anticancer drug efficacy evaluation system using the mouseâ€™s biological system.

Employees

147

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
26-10-07	₩27,850.00	-7.01%	173,364
26-10-06	₩29,950.00	+2.57%	163,636
26-10-02	₩29,200.00	-3.79%	166,864
26-10-01	₩30,350.00	-0.33%	100,533
26-09-30	₩30,450.00	+2.53%	119,651

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 2026-10-06			5-day change	1st Jan Change
29,950.00 ^KRW	+2.57%		+0.84%	+67.79%

09-20	JS Link, Inc.(KOSDAQ:A127120) added to S&P Global BMI Index	CI
08-14	JS Link, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Market Cap	968B 722M 646M 602M 547M 1.03B 69.89B 1.04B 7.24B 2.83B 35.54B 2.71B 2.65B 114B	P/E 2024	-10.5x	P/E 2025	-29.7x
Enterprise Value	971B 725M 647M 604M 549M 1.03B 70.1B 1.04B 7.26B 2.84B 35.65B 2.72B 2.66B 115B	EV / Sales 2024	8.93x	EV / Sales 2025	29.6x
Free-Float	72.57%	Yield 2024 *	-	Yield 2025	-

09-20	JS Link, Inc.(KOSDAQ:A127120) added to S&P Global BMI Index	CI
08-14	JS Link, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-29	JS Link, Inc. announced that it has received KRW 53.392992 billion in funding from Lynas Rare Earths Limited	CI
07-07	REalloys Inc. and JS Link Inc. Sign Non-Binding Strategic Letter of Intent to Develop Fully Integrated North American Rare Earth Magnet Platform	CI
07-06	Australia's Lynas, South Korea's JS Link sign deal for Malaysia magnet factory	RE
07-06	Australia's Lynas signs deal with South Korea's JS Link to develop Malaysian magnet factory	RE
06-25	JS Link, Inc. announced that it has received KRW 30 billion in funding from Joosung Sea & Air Co. Ltd	CI
05-15	JS Link, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-12	JS Link, Inc. announced that it expects to receive KRW 5 billion in funding	CI
05-12	JS Link, Inc. announced that it expects to receive KRW 30 billion in funding	CI
03-23	JS Link, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
02-02	JS Link, Inc. announced that it has received KRW 20.00000805 billion in funding from Orbitech Co., Ltd., Joosung Sea & Air Co. Ltd	CI
11-14	JS Link, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI

1 day	+2.57%
1 week	+0.84%
Current month	-1.64%
1 month	-10.86%
3 months	-18.83%
6 months	-26.05%
Current year	+67.79%

JS Link, Inc. Stock

Stocks

A127120

KR7127120004

Biotechnology & Medical Research

Valuation: JS Link, Inc.

Chart: JS Link, Inc.

Latest news: JS Link, Inc.

Press Releases: JS Link, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: JS Link, Inc.

Latest insider transactions

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

1 week	28,800	30,750
1 month	28,800	34,850
Current year	16,230	49,900
1 year	13,860	49,900
3 years	1,775	49,900
5 years	1,775	49,900
10 years	1,775	49,900

Manager	Title	Age	Since
Jun-Young Lee CEO	Chief Executive Officer	58	2024-08-22
Cheol-Gu Sim CEO	Chief Executive Officer	47	2023-10-19
Kenji Gonishi PRN	Corporate Officer/Principal	58	2024-08-22

Director	Title	Age	Since
Cheol-Gu Sim BRD	Director/Board Member	47	2023-10-19
Jun-Young Lee BRD	Director/Board Member	58	2024-08-22
Kenji Gonishi BRD	Director/Board Member	58	2024-08-22

Date	Insider	Type	Quantity	% Market Cap.
11/19/25	Jin-soo Park	Buy	1,500	0.0047%
11/17/25	Jin-soo Park	Buy	5,000	0.0157%
11/4/25	Jin-soo Park	Buy	87,138	0.2742%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
JS LINK, INC.	+2.57%	+0.84%	+43.65%	+713.86%	778M
WUXI APPTEC CO., LTD.	+4.16%	+4.16%	+49.37%	+94.17%	74.69B
ARGENX SE	+0.46%	-0.97%	+23.51%	+79.34%	58.81B
LONZA GROUP AG	+0.17%	+0.35%	+6.85%	+34.55%	48.45B
REVOLUTION MEDICINES, INC.	+0.50%	-2.14%	+331.33%	+702.20%	42.84B
IQVIA HOLDINGS INC.	-0.72%	-3.99%	+28.50%	+29.94%	42.79B
BEONE MEDICINES AG	+0.34%	-0.52%	+6.56%	+109.35%	41.25B
CELLTRION, INC.	-0.11%	+1.96%	+9.19%	+52.66%	31.13B
BIONTECH SE	-0.50%	-3.10%	-10.19%	-14.35%	24.05B
INSMED INCORPORATED	-3.32%	-10.86%	-37.32%	+316.28%	22.98B
Average	+0.36%	-2.05%	+45.14%	+211.80%	38.78B
Weighted average by Cap.	+0.67%	-1.79%	+52.36%	+150.51%

	2024	2025
Net sales	15.91B 11.87M 10.61M 9.9M 8.99M 16.93M 1.15B 17.06M 119M 46.47M 584M 44.58M 43.62M 1.88B	19.32B 14.42M 12.88M 12.02M 10.92M 20.56M 1.39B 20.72M 144M 56.43M 709M 54.13M 52.96M 2.28B
Net income	-10.8B -8.06M -7.2M -6.72M -6.11M -11.5M -780M -11.58M -80.77M -31.56M -397M -30.27M -29.62M -1.28B	-16.45B -12.28M -10.97M -10.23M -9.3M -17.51M -1.19B -17.64M -123M -48.04M -604M -46.09M -45.09M -1.94B
Net Debt	14.39B 10.74M 9.6M 8.96M 8.13M 15.32M 1.04B 15.44M 108M 42.05M 529M 40.33M 39.46M 1.7B	2.88B 2.15M 1.92M 1.79M 1.63M 3.07M 208M 3.09M 21.55M 8.42M 106M 8.08M 7.9M 340M